WallStSmart
LFCR

Lifecore Biomedical Inc.

NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$5.07
+2.63% today

Updated 2026-04-30

Market cap
$190.38M
P/E ratio
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
52W range
$4 – $9
Volume
0.4M

WallStSmart proprietary scores

30
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
5.0
Quality
C+
3.0
Profitability
D
3.0
Valuation
D
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$6.50
+28.21%
12-Month target
Intrinsic (DCF)
$5.87
Margin of safety
-23.17%
1 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $3.61M — positive
Risks
- Thin margins at -23.80%
- Revenue declining -3.80% QoQ
- 23.17% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$185.79M$111.27M$128.26M$128.87M$129.47M
Net income$-97.43M$-116.72M$12.01M$-38.72M$-7.97M
EPS$-1.27
Free cash flow$-52.53M$-52.53M$-18.14M$-13.62M$3.61M
Profit margin-52.44%-104.89%9.37%-30.04%-23.80%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
LFCR$190.38M302.73.03.05.0-23.17%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Lifecore Biomedical Inc. trades at $5.07. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $129.47M. with profit margins at -23.80%. Our DCF model estimates intrinsic value at $5.87.

Frequently asked questions

What is Lifecore Biomedical Inc.'s stock price?
Lifecore Biomedical Inc. (LFCR) trades at $5.07.
Is Lifecore Biomedical Inc. overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $5.87.
What is the price target of Lifecore Biomedical Inc. (LFCR)?
The analyst target price is $6.50, representing +28.2% upside from the current price of $5.07.
What is the intrinsic value of Lifecore Biomedical Inc. (LFCR)?
Based on our DCF model, intrinsic value is $5.87, a -23.2% margin of safety versus $5.07.
What is Lifecore Biomedical Inc.'s revenue?
TTM revenue is $129.47M.

Company info

SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1.47x
ROE-76.40%
Beta0.88
50D MA$5.52
200D MA$7.04
Shares out0.04B
Float0.02B
Short ratio
Avg volume0.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years